Underlying Causes
Malaria is caused by single-celled parasites of the genus Plasmodium. The disease is transmitted to humans primarily through the bite of an infected female Anopheles mosquito. When the mosquito bites, it injects the parasites into the bloodstream. These parasites travel to the liver, where they mature and multiply. After several days to weeks, the parasites leave the liver and infect red blood cells, causing them to burst and releasing more parasites into the bloodstream. There are several species of the parasite that infect humans, with Plasmodium falciparum being the most dangerous and likely to cause severe disease, while Plasmodium vivax and Plasmodium ovale can remain dormant in the liver.

Risk Factors
The primary risk factor is living in or traveling to areas where malaria is common, particularly tropical and subtropical regions such as sub-Saharan Africa, South and Southeast Asia, and parts of Central and South America. Individuals with no immunity to the disease are at higher risk of developing severe complications. This includes young children and infants, older adults, pregnant women and their unborn children, and travelers coming from areas with no malaria. Exposure is most likely to occur between dusk and dawn when the Anopheles mosquitoes are most active. In rare cases, transmission can occur through blood transfusions, organ transplants, or sharing needles.

Prevention Strategies
Preventing mosquito bites is the most effective way to avoid infection. Strategies include using insect repellents containing DEET or picaridin on exposed skin and sleeping under insecticide-treated bed nets, especially in high-risk areas. Wearing long-sleeved shirts and long pants during the evening and night offers physical protection. Travelers to endemic areas often take antimalarial medication (chemoprophylaxis) prescribed by a doctor before, during, and after their trip to prevent the parasites from establishing an infection. Vaccines are now available for children living in regions with moderate to high transmission rates, offering partial protection against the disease. Vector control measures, such as indoor residual spraying of insecticides, help reduce mosquito populations in affected communities.

Signs and Symptoms
Symptoms typically appear 10 days to 4 weeks after infection, though some types can remain dormant for up to a year. The illness often starts with flu-like symptoms that may come and go in cycles. Common signs include:

• High fever and shaking chills
• Profuse sweating
• Headache
• Nausea and vomiting
• Muscle aches and joint pain
• Fatigue
• Abdominal pain or diarrhea

Diagnosing the Condition
Clinicians identify malaria primarily through blood tests. The gold standard for diagnosis is the microscopic examination of a blood smear, where a drop of blood is stained and viewed under a microscope to visualize the parasites. In areas where microscopy is not available, Rapid Diagnostic Tests (RDTs) are commonly used to detect specific antigens (proteins) produced by the malaria parasite in the blood. These tests can provide results in less than 30 minutes. Polymerase chain reaction (PCR) tests may be used to identify the specific type of parasite or detect low levels of infection, though they take longer to process. Doctors also perform a physical exam to check for an enlarged spleen or liver.

Differential Diagnosis
Because early symptoms resemble the flu or other viral illnesses, malaria can be confused with conditions like influenza, dengue fever, typhoid fever, or viral hepatitis. A travel history is crucial for distinguishing malaria from these other infections.

Medical Treatments
Treatment aims to eliminate the parasite from the bloodstream. The choice of medication depends on the type of parasite causing the infection, the severity of symptoms, the patient's age, and whether the parasite is resistant to certain drugs. Artemisinin-based combination therapies (ACTs) are currently the standard treatment for uncomplicated malaria caused by P. falciparum. Other common antimalarial drugs include chloroquine, atovaquone-proguanil, and doxycycline. For P. vivax and P. ovale infections, a second medication (primaquine or tafenoquine) is often prescribed to eradicate the dormant liver stage and prevent relapse. Severe malaria is a medical emergency requiring hospitalization and intravenous (IV) medications, such as injectable artesunate, followed by a full course of oral medication once the patient improves.

When to Seek Medical Care
Immediate medical attention is necessary if you experience a fever while living in or after traveling to a malaria-endemic region. This applies even if the travel occurred several months prior. Seek emergency care if symptoms are severe, such as confusion, difficulty breathing, seizures, or loss of consciousness. Red-flag symptoms indicating severe malaria include extreme weakness, yellowing of the skin and eyes (jaundice), and dark or bloody urine. Routine follow-up may be required to ensure the infection has cleared completely.

Severity and Complications
Malaria ranges from a mild, uncomplicated febrile illness to severe, life-threatening disease. Plasmodium falciparum is responsible for the majority of severe cases and deaths. If not treated promptly, the infection can progress rapidly. Severe malaria can cause serious complications, including cerebral malaria (swelling of the brain leading to seizures and coma), severe anemia (due to the destruction of red blood cells), and respiratory distress (fluid in the lungs). Other complications may include acute kidney failure, liver failure, and dangerously low blood sugar (hypoglycemia). Children and pregnant women are at the highest risk for these severe outcomes.

Prognosis and Outlook
The prognosis is generally excellent for patients with uncomplicated malaria who receive prompt and appropriate treatment; most recover completely with no long-term effects. However, severe malaria carries a significant risk of mortality, even with intensive care. Surviving severe cerebral malaria can sometimes lead to long-term neurological deficits, such as learning disabilities or epilepsy, particularly in children. Immunity to malaria is not absolute; individuals can be reinfected multiple times, although repeated infections in endemic areas often lead to partial immunity that reduces the severity of subsequent episodes.

Impact on Daily Activities
During the acute phase of the infection, individuals are typically too ill to attend work or school due to high fever and extreme fatigue. Recovery time varies; while the parasite may be cleared quickly with medication, post-infection fatigue and weakness can persist for several weeks. Patients recovering from severe malaria may require a longer period of rehabilitation and monitoring for potential organ damage or neurological issues. Emotional distress is common, particularly for travelers who contract the disease unexpectedly or for parents caring for sick children.

Questions to Ask Your Healthcare Provider
To better understand the condition and recovery, consider asking the following questions:

• What specific type of malaria parasite do I have?
• Do I need to take extra medication to prevent the infection from coming back (relapsing)?
• What are the side effects of the prescribed antimalarial drugs?
• How long will it take for me to feel normal again?
• Are there any warning signs that should prompt me to return to the hospital immediately?
• What precautions should I take if I plan to travel to a tropical area again?

Q: Is malaria contagious from person to person?
A: No, malaria is not spread directly from person to person like a cold or the flu. You cannot catch it by sitting next to or touching someone who has it. It is almost exclusively transmitted through the bite of an infected mosquito.

Q: Can I get malaria more than once?
A: Yes, having malaria once does not provide lifelong protection. You can be infected again if you are bitten by another infected mosquito. However, people living in areas where the disease is common may develop partial immunity that makes symptoms less severe over time.

Q: Is there a vaccine for malaria?
A: Yes, vaccines have been developed and recommended by the World Health Organization (WHO), specifically for children living in regions with moderate to high malaria transmission. These vaccines significantly reduce the risk of severe disease but are not typically available for travelers.

Q: Can malaria be cured completely?
A: Yes, malaria is a curable disease. With the right combination of antimalarial drugs taken for the correct duration, the parasite can be completely eliminated from the body.

Q: Why do symptoms sometimes return months after treatment?
A: Certain species of the malaria parasite, specifically P. vivax and P. ovale, can lie dormant in the liver for weeks, months, or even years. If the treatment did not include medication to target this liver stage, the parasites can reactivate and cause a relapse.